Search results for: chemistry & pharma

CASGEVY™/Exa-cel: UK Approves World’s First Gene Therapy for Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

On 16 November 2023, the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK approved the world’s first CRISPR-based gene therapy, which is also the first gene therapy for the treat...

GJE Recognised by Chambers and Partners 2024

We are pleased to be recognised in the 2024 Chambers and Partners guide. Chambers and Partners identifies the best law firms globally through interviews and client feedback.  The directory a...

GJE No.1 in the Financial Times’ “Europe’s Leading Patent Firms 2023” Awards

It brings us great pride to announce that GJE has been listed first place on the Financial Times leader board of top firms in the “Europe’s Leading Patent Law Firms 2023” annual awards.  GJ...

GJE Recognised by Chambers and Partners 2023

We are pleased to be recognised in the 2023 Chambers and Partners guide. Chambers and Partners identifies the best law firms globally through interviews and client feedback.  The directory assess...

Organ on a Chip: Technological and Patent Landscape

The development of drugs can be a slow process due to the need for safety and extensive testing. Before a drug can proceed to human trials, it is important to ascertain information relating to efficac...

GJE Top-Ranked in the Financial Times’ “Europe’s Leading Patent Law Firms 2022” Awards

For a fourth consecutive year, GJE has been top-ranked on the Financial Times’ leader board of best firms in “Europe’s Leading Patent Law Firms 2022” annual awards. The firm received five Gold...

Partnership News

We are delighted to announce that Ross Cummings and Ian Jones have joined the Partnership. Ross Cummings joined GJE in 2017, having previously worked at another top tier firm of patent and trade mark ...

GJE No.1 in the Financial Times “Europe’s Leading Patent Firms 2021” Awards

GJE has been listed joint first place with two other firms on the Financial Times leader board of top firms in the “Europe’s Leading Patent Law Firms 2021” annual awards.  The firm received...

Chemical Patents – Securing Protection for Your Invention in Association with IOM3 | 22.06.21

Tuesday 22nd of June, 2021, 2:00pm (London UK – BST) 60 mins What will the talk cover?  Inventions dependent on chemistry span many different technology areas – from coatings and polymers...

Oppositions at the European Patent Office – An Introduction | 15.12.20

Tuesday 15th December 2020, 2:00pm (London UK – BST) 45mins What will the talk cover? Gill Jennings & Every has one of the most experienced and active patent opposition practices in Europe, ...